Robbert Vorhoff
About Robbert Vorhoff
Robbert Vorhoff, age 46, is an independent director of Alignment Healthcare (ALHC) and has served on the Board since 2014. He is Managing Director, Investment Committee member, and Global Head of Healthcare at General Atlantic; he holds a B.S. in Commerce (Finance) from the University of Virginia. His core credentials cited by ALHC include health care industry expertise and capital markets experience .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| General Atlantic | Managing Director; Global Head of Healthcare; Investment Committee member | Since 2003 (joined GA in 2003) | Growth investor/board governance across healthcare portfolio |
| Greenhill & Co. | M&A and restructuring advisory; later Greenhill Capital Partners (private equity) | Prior to 2003 | Transaction execution and PE investing |
External Roles
| Organization | Role | Type | Tenure/Notes |
|---|---|---|---|
| Equality Health | Board member | Private | Current |
| Included Health | Board member | Private | Current |
| Marathon Health | Board member | Private | Current |
| NationsBenefits | Board member | Private | Current |
| Suvida Healthcare | Board member | Private | Current |
| Eventus Whole Health | Board member | Private | Current |
| Author Health | Board member | Private | Current |
| Align Networks; Alternate Solutions Health Network; A Place for Mom; eviCore Healthcare; Landmark Health; Oak Street Health; WelbeHealth; OneOncology; MedExpress | Prior board member | Mix of private/public (Oak Street Health formerly public) | Prior |
| Other public company boards (current) | — | — | None disclosed |
Board Governance
- Committee assignments: Compensation Committee member (not Chair) .
- Independence: Board determined Vorhoff is independent under Nasdaq/SEC rules (independence evaluated including affiliations with General Atlantic, ALHC’s Lead Sponsor) .
- Attendance: In 2024, all directors except Dr. McClellan attended at least 75% of combined Board and committee meetings; the Board held 7 meetings; Compensation Committee held 9 .
- Executive sessions: Independent directors meet in executive session at least quarterly; Board maintains a Lead Independent Director structure when Chair is not independent .
Fixed Compensation
| Component (2024) | Amount | Detail |
|---|---|---|
| Fees Earned or Paid in Cash | $16,875 | Includes cash retainer elected and committee member fees (Compensation Committee members receive $7,500 annually in 2024) |
| Stock Awards (RSUs grant-date fair value) | $250,000 | Annual director equity; vesting on first anniversary of grant date |
| Total | $266,875 | Paid under Non-Employee Director Compensation Policy |
Policy reference points:
- 2024 aggregate annual director compensation value: $250,000 (cash retainer elected from $0–$100,000; balance in RSUs/restricted shares) .
- Committee fees (2024): Compensation Committee Chair $20,000; members $7,500; Audit Chair $25,000; Audit members $10,000; NCGCC Chair $20,000; NCGCC members $7,500 .
- 2025 aggregate increased to $290,000; certain committee retainers increased (e.g., Compensation Chair to $25,000; members to $10,000) .
Performance Compensation
| Element | Structure | Metrics | Vesting |
|---|---|---|---|
| Director equity grants | Time-based RSUs | None (no performance-based director metrics disclosed) | RSUs vest on first anniversary of grant date; optional deferral elections available |
ALHC’s performance share unit framework applies to executives, not directors; director awards are retainer-linked time-vested RSUs .
Other Directorships & Interlocks
| Item | Disclosure |
|---|---|
| Compensation Committee interlocks | None among members (Kosecoff, McCarthy, Vorhoff) in 2024; no insider participation |
| Independent compensation consultant | FW Cook engaged May 2024 for executive/director pay advice |
| Lead Sponsor influence | Stockholders Agreement grants General Atlantic (Lead Sponsor) board designation rights based on ownership thresholds |
Expertise & Qualifications
- Health care industry expertise; capital markets experience (as cited by ALHC) .
- Managing Director and Global Head of Healthcare at General Atlantic; extensive healthcare board experience across payors/providers/services .
- Education: B.S. in Commerce (Finance) from University of Virginia .
Equity Ownership
| Measure | Value | Notes |
|---|---|---|
| Beneficial ownership (common shares) | 135,716 shares; <1% of outstanding | |
| Unvested RSUs (as of 12/31/2024) | 50,000 RSUs | |
| Stock options | None disclosed for Vorhoff | |
| Pledging/Hedging policy | Company prohibits pledging and short sales; allows only long-term hedges with pre-clearance; anti-hedging/anti-pledging policies in place | |
| Director stock ownership guidelines | Company maintains officer/director ownership requirements; specific multiples not disclosed |
Governance Assessment
- Strengths: Independent status; active role on Compensation Committee; robust board processes (annual self-evaluations; executive sessions; clawback; anti-hedging/anti-pledging), and high overall director engagement (Board/committee attendance practices) .
- Alignment: Director compensation is predominantly equity, with modest cash; Vorhoff elected minimal cash relative to equity ($16,875 cash; $250,000 RSUs), supporting ownership alignment .
- Potential conflicts (monitoring focus): Vorhoff’s senior role at General Atlantic, ALHC’s Lead Sponsor (31.0% ownership), combined with GA’s board designation rights, can create perceived sponsor influence; Board explicitly considered GA affiliations in independence determinations; related-party transactions are overseen by the Audit Committee pursuant to policy .
- RED FLAGS: None disclosed specific to Vorhoff (no related-party transactions or interlocks requiring disclosure; attendance met ≥75% threshold). Ongoing monitoring warranted for sponsor influence due to GA’s rights and portfolio overlaps in healthcare ecosystems .